Nicholas Buxton

Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom.

Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom.

GAM International Management Ltd. (GIML) is the Great Britain-based alternative investment management subsidiary of GAM (UK) Ltd., ultimately owned by GAM Holding AG (SWX: GAM) in Switzerland. Headquartered in London, GIML was founded in 1984 and provides investment management services to a range of pooled investment vehicles, such as GAM Funds, corporate and public pension plans, trusts, estates, charitable organizations, foundations, endowments, corporations and other business entities.

CECP Advisors (CECP-UK) is the Great Britain-based venture capital subsidiary of global private equity investment group Carlyle Group LLC, ultimately held by the Carlyle Group LP (NASDAQ: CG) in the US. The group has additional offices throughout Europe in Barcelona, Frankfurt, Luxembourg, Milan, Munich, Paris, Stockholm and Warsaw. Formerly known as CECP Investment Advisors Ltd., the firm was established in 1997 and is based in London. They cooperate closely with Carlyle offices in Paris, Munich, Milan and Barcelona, sub-advising private equity funds for the parent group. They manage the Carlyle Europe Partners series of buyout funds, as well as venture capital funds, all domiciled in Luxembourg. Their international clientele includes public pension funds and agencies, financial institutions, high-net worth individuals and corporate pension schemes.

AZ Electronic Materials USA Corp. develops and manufactures technology products for use in integrated circuits and devices. The firm's products are used in the manufacture of flat screen digital TV's, PC's, mobile phones, navigation devices, and medical imaging equipment. The company has facilities in China, the United States, Japan, Korea, France, Germany, Singapore, Hong Kong, and the United Kingdom. The company is located in Branchburg, NJ.

RAC Group Ltd. provides motoring products and services. It offers breakdown coverage, insurance, vehicle repair and recovery, and roadside planner services. The company was founded in 1897 and is headquartered in Walsall, the United Kingdom.

Firth Rixson Ltd. manufactures and markets rolled jet engine rings, forgings, and metal products. The company was founded on May 24, 1928 and is headquartered in Sheffield, the United Kingdom.

Britax Childcare Ltd. manufactures, designs, and distributes children's car seats, wheeled goods, and related accessories. The company was founded on February 21, 2000 and is headquartered in Camberley, the United Kingdom.

Tiger Topco Ltd. functions as an investment holding British company.

Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom.

The Carlyle Group LP (Global Private Equity) is a private equity firm founded in the year 1990 by William E. Conway, Jr. and Daniel A. D'Aniello. The firm is headquartered in Washington DC.

Sullivan Street Partners Ltd (Sullivan Street Partners) is a private equity firm founded in 2010 by Layton Tamberlin and Richard Sanders. The firm is headquartered in London, United Kingdom.

OVE Arup & Partners International Ltd. provides scientific and technical consulting services. The company is headquartered in London, the United Kingdom.

Founded in 1975, Arup Gulf Ltd. is a part of OVE Arup Partnership Trustees Ltd. that provides engineering, scientific, and technical consulting services. The company is based in London, UK.

Part of Ove Arup Partnership Charitable Trust, Ove Arup & Partners Ltd. is a British company that provides engineering consulting services. The company is based in London, UK and was founded in 1977.

Arup Group Ltd. provides engineering, design, planning and project management consulting services. The company has offices across Europe, North America, Africa, Australasia and South East Asia. It offers building design, economics and planning, infrastructure design, management consulting and specialist technical services. The firm was founded by Ove Arup in 1946 and is headquartered in London, the United Kingdom.

The Blackmoor Estate Ltd. is a family-run farm located near in the UK that has been growing traditional and new varieties of English apples and pears since the 1920s. The British company also grows cherries and offer cider and apple juice on the farm.

Gresham College is an educational institution that offers a series of lectures on various topics related to business and personal development. The institution is based in London, UK, and the CEO of the private company is Wendy Piatt. The lectures cover essential skills such as time management, public speaking, pursuing a purposeful career, mental and physical wellness, critical thinking, and adopting a growth mindset. The lectures are delivered by experts in their respective fields, such as Professor Bourke, who is a historian and academic, currently working at the University of London.

The Francis Crick Institute Ltd. operates as a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. The firms works helps to understand why disease develops and to find new ways to treat, diagnose, and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. The company is headquartered in London, the United Kingdom.

SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London.

Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK.

Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom.

LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.

MedNova Ltd. manufactures medical devices. The company specializes in the development of minimally-invasive vascular products for the protection and repair of the heart, brain and blood vessels. It was founded in 1996 and is headquartered in Galway, Ireland.

RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.

SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom.

Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.

Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom.

Part of SV Health Investors LLP, SV Health Investors UK Ltd. is a company that provides investment services. The company is based in London, UK and was founded in 2004.

Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom.

Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom.

Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer.

Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom.